181 related articles for article (PubMed ID: 36250711)
1. Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis.
Rebsamen M; McKinley R; Radojewski P; Pistor M; Friedli C; Hoepner R; Salmen A; Chan A; Reyes M; Wagner F; Wiest R; Rummel C
Hum Brain Mapp; 2023 Feb; 44(3):970-979. PubMed ID: 36250711
[TBL] [Abstract][Full Text] [Related]
2. The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis.
Lie IA; Kerklingh E; Wesnes K; van Nederpelt DR; Brouwer I; Torkildsen Ø; Myhr KM; Barkhof F; Bø L; Vrenken H
Eur Radiol; 2022 May; 32(5):3576-3587. PubMed ID: 34978580
[TBL] [Abstract][Full Text] [Related]
3. Cervical and thoracic cord atrophy in multiple sclerosis phenotypes: Quantification and correlation with clinical disability.
Mina Y; Azodi S; Dubuche T; Andrada F; Osuorah I; Ohayon J; Cortese I; Wu T; Johnson KR; Reich DS; Nair G; Jacobson S
Neuroimage Clin; 2021; 30():102680. PubMed ID: 34215150
[TBL] [Abstract][Full Text] [Related]
4. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
[TBL] [Abstract][Full Text] [Related]
5. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
6. Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of cross-sectional and longitudinal segmentations.
Jovicich J; Marizzoni M; Sala-Llonch R; Bosch B; Bartrés-Faz D; Arnold J; Benninghoff J; Wiltfang J; Roccatagliata L; Nobili F; Hensch T; Tränkner A; Schönknecht P; Leroy M; Lopes R; Bordet R; Chanoine V; Ranjeva JP; Didic M; Gros-Dagnac H; Payoux P; Zoccatelli G; Alessandrini F; Beltramello A; Bargalló N; Blin O; Frisoni GB;
Neuroimage; 2013 Dec; 83():472-84. PubMed ID: 23668971
[TBL] [Abstract][Full Text] [Related]
7. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
8. Focal cortical thinning in patients with stable relapsing-remitting multiple sclerosis: cross-sectional-based novel estimation of gray matter kinetics.
Orbach L; Menascu S; Hoffmann C; Miron S; Achiron A
Neuroradiology; 2018 Feb; 60(2):179-187. PubMed ID: 29285552
[TBL] [Abstract][Full Text] [Related]
9. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
Biberacher V; Schmidt P; Keshavan A; Boucard CC; Righart R; Sämann P; Preibisch C; Fröbel D; Aly L; Hemmer B; Zimmer C; Henry RG; Mühlau M
Neuroimage; 2016 Nov; 142():188-197. PubMed ID: 27431758
[TBL] [Abstract][Full Text] [Related]
10. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
[TBL] [Abstract][Full Text] [Related]
11. Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study.
Mallik S; Muhlert N; Samson RS; Sethi V; Wheeler-Kingshott CA; Miller DH; Chard DT
Mult Scler; 2015 Apr; 21(4):423-32. PubMed ID: 25145689
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced double inversion recovery sequence for patients with multiple sclerosis: feasibility of subtraction images between pre- and post-contrast images.
Tomura N; Saginoya T; Sanpei T; Konno T; Fujihara K
Acta Radiol; 2023 Feb; 64(2):719-724. PubMed ID: 35306900
[TBL] [Abstract][Full Text] [Related]
13. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
14. Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data.
Sampat MP; Berger AM; Healy BC; Hildenbrand P; Vass J; Meier DS; Chitnis T; Weiner HL; Bakshi R; Guttmann CR
AJNR Am J Neuroradiol; 2009 Oct; 30(9):1731-9. PubMed ID: 19696139
[TBL] [Abstract][Full Text] [Related]
15. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
16. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
[TBL] [Abstract][Full Text] [Related]
17. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study.
Duan Y; Liu Y; Liang P; Jia X; Yu C; Qin W; Sun H; Liao Z; Ye J; Li K
Eur J Radiol; 2012 Feb; 81(2):e110-4. PubMed ID: 21316170
[TBL] [Abstract][Full Text] [Related]
18. Multiple sclerosis as a model to investigate SARS-CoV-2 effect on brain atrophy.
Rebsamen M; Friedli C; Radojewski P; Diem L; Chan A; Wiest R; Salmen A; Rummel C; Hoepner R
CNS Neurosci Ther; 2023 Feb; 29(2):538-543. PubMed ID: 36479826
[TBL] [Abstract][Full Text] [Related]
19. Direct cortical thickness estimation using deep learning-based anatomy segmentation and cortex parcellation.
Rebsamen M; Rummel C; Reyes M; Wiest R; McKinley R
Hum Brain Mapp; 2020 Dec; 41(17):4804-4814. PubMed ID: 32786059
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
Zivadinov R; Ramasamy DP; Vaneckova M; Gandhi S; Chandra A; Hagemeier J; Bergsland N; Polak P; Benedict RH; Hojnacki D; Weinstock-Guttman B
Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
